Active Pharmaceutical Ingredients (APIs)

  • Risedronate Sodium

    • API Product   :   

      Risedronate Sodium

    • CEP   :   

      -

    • WCC   :   

      ?

    • Therapeutic Use    :   

      Other Drugs For Disorders Of The Musculo-Skeletal System

    • Originator   :   

      Procter & Gamble

    • CAS No.    :   

      105462-24-6

    • Trade Name.   :   

      ACTONEL

    • Molecular Weight   :   

      283.112 g/mol

    • Molecular Formula   :   

      C7H11NO7P2

    Application

    Risedronate is used by adults to treat a disease that weakens bones (Paget's disease). This medication helps to reduce bone pain and may prevent long-term complications from this disease. Risedronate works by slowing bone loss to help maintain strong bones and reduce the risk of broken bones (fractures).

    General Description

    Risedronic acid (INN) often used as its sodium salt risedronate sodium (USAN) is a bisphosphonate used to strengthen bone, treat or prevent osteoporosis, and treat Paget's disease of bone. It is produced and marketed by Warner Chilcott, Sanofi-Aventis, and in Japan by Takeda under the trade names Actonel, Atelvia, and Benet. It is also available in a preparation that includes a calcium carbonate supplement, as Actonel with Calcium.